Trial
NCT02325349
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Advanced Head and Neck Carcinoma
Intervention
radiopharmaceutical (Flotegatide (18F) or RGD (68Ga)
Why stopped
Change in protocol strategy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-19